Journal article
Seropositive symmetrical inflammatory polyarthritis appearing after treatment with fludarabine in a patient with non-hodgkin's lymphoma
Abstract
Fludarabine is an important therapeutic option in patiens with chronic lymphocytic leukemia/diffuse small cell lymphoma. Adverse effects of fludarabine include myelosuppression, immunosuppression and autoimmune phenomena. We describe a case of symmetrical inflammatory seropositive polyarthritis consistent with rheumatoid arthritis in a patient with indolent non-Hodgkin's lymphoma who was being treated with fludarabine. A 67 year old Caucasian …
Authors
Kouroukis C; Boulos P; Haines P; Adachi JD; Meyer RM
Journal
Blood, Vol. 96, No. 11 PART II,
Publication Date
January 1, 2000
ISSN
0006-4971